Insight

Jul 28, 2025, 15:41

How Autoantibodies Influence Cancer Patients’ Response to Immunotherapy – Fred Hutch Cancer Center

Fred Hutch Cancer Center shared a post on X, about a recent article by Yile Dai et al. published in Nature:

“A landmark study published in Nature by Aaron Ring et al. has revealed that autoantibodies — immune proteins traditionally associated with autoimmune disease — may profoundly influence how cancer patients respond to immunotherapy.”

Title: Humoral determinants of checkpoint immunotherapy

Authors: Yile Dai, Lilach Aizenbud, Kai Qin, Matthew Austin, Jillian R. Jaycox, Joseph Cunningham, Eric Y. Wang, Lin Zhang, Suzanne Fischer, Sean M. Carroll, Helen van Aggelen, Yuval Kluger, Kevan C. Herold, Leon Furchtgott, Harriet M. Kluger, Aaron M. Ring

Read the Full Article on Nature

How Autoantibodies Influence Cancer Patients' Response to Immunotherapy - Fred Hutch Cancer Center

More posts featuring Fred Hutch Cancer Center.

Aaron M. Ring Autoantibodies Eric Y. Wang Fred Hutch Cancer Center Harriet M. Kluger Helen van Aggelen immunotherapy Jillian R. Jaycox Joseph Cunningham Kai Qin Kevan C. Herold Leon Furchtgott Lilach Aizenbud Lin Zhang Matthew Austin Sean M. Carroll Suzanne Fischer Yile Dai Yuval Kluger

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth